Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire

This retrospective study analyzed the impact of demographic and transplantation variables on outcomes of 1108 patients who have undergone allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning (RIC HSCT) for hematological malignancies and were reported to the Société...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental hematology 2008-05, Vol.36 (5), p.535-544
Hauptverfasser:	Michallet, Mauricette, Le, Quoc-Hung, Mohty, Mohamad, Prébet, Thomas, Nicolini, Franck, Boiron, Jean Michel, Esperou, Hélène, Attal, Michel, Milpied, Noel, Lioure, Bruno, Bordigoni, Pierre, Yakoub-Agha, Ibrahim, Bourhis, Jean-Henri, Rio, Bernard, Deconinck, Eric, Renaud, Marc, Chir, Zina, Blaise, Didier
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Advanced Basic Science Aged Antilymphocyte Serum Antilymphocyte Serum - administration & dosage Busulfan Busulfan - administration & dosage Child Child, Preschool Disease-Free Survival Female Follow-Up Studies France Graft vs Host Disease Graft vs Host Disease - diagnosis Graft vs Host Disease - etiology Graft vs Host Disease - therapy Hematologic Neoplasms Hematologic Neoplasms - diagnosis Hematologic Neoplasms - therapy Hematology, Oncology and Palliative Medicine Hematopoietic Stem Cell Transplantation Hematopoietic Stem Cell Transplantation - adverse effects Humans Immunology Infant Life Sciences Male Middle Aged Multivariate Analysis Predictive Value of Tests Registries Remission Induction Retrospective Studies Risk Factors Survival Analysis Time Transplantation Conditioning Transplantation Conditioning - methods Transplantation, Homologous Treatment Outcome Vidarabine Vidarabine - administration & dosage Vidarabine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!